ProImmune service spikes immunogenic biologics
UK company ProImmune has launched a suite of services to help drugmakers determine at an early stage whether a biologic drug will elicit an immune response in humans.
Archives for November 24, 2008
AZ to slash more European jobs and ramp-up China investment
AstraZeneca is to cut 1,400 jobs and close more manufacturing facilities by 2013, as it attempts to slim down in preparation for impending generic competition for some of its cornerstone drugs.
Cargill talks about its excipient portfolio
Cargill discusses its C*PharmDex and Zerose Erythritol excipients at this year's CPhI in Frankfurt, Germany.
Patheon broadens portfolio with new commercial partners
Patheon has signed a slew of agreements to boost its portfolio of contract drug development and manufacturing services, forging new alliances with Omnicare, Depomed, Senopsys and Solvias.
Encorium delays financial results
Clinical research organisation Encorium has postponed the release of its third quarter results but said it still expects the figures to be in line with its most up-to-date guidance.
FDA publishes guidance on process validation
The US Food and Drug Administration (FDA) has issued draft guidance on process validation, updating its 1987 document to incorporate advances in manufacturing technology and thinking.
Jubilant buys into EDC sector
India’s Jubilant Organosys has bolstered its mid-range contract research portfolio by buying Canadian electronic data capture (EDC) specialist TrialStat ClinicalAnalytics.
Orbus ducks out of contract manufacturing
Canada’s Orbus Pharma has decided to exit the contract manufacturing business, saying that the division “posed a distraction to the core business and generated low or negative margins.”
DPT Laboratories' F&S Award
Reaction to the F&S Best Practices award
DPT highlights R&D prowess at AAPS 2008
DPT Laboratories chose this year’s AAPS in Atlanta to showcase its research and development capability with a unique poster presentation examining the role of various excipients in nasal drug delivery applications.
Raw material contamination a hot topic at AAPS
The pharmaceutical industry’s vigilance in ensuring the safety of raw materials was criticised at this year’s AAPS, with significant, challenging alterations needed to improve the system.